 Avalon GloboCare Corp. AVCO, a clinical-stage global developer of cell-based technologies and therapeutics, announced today that the Company has appointed Professor Uwe B. Sleytr to its Scientific and Clinical Advisory Board. Professor Uwe B. Sleytr is a world-renowned scientist and pioneer in nanobiotechnology. 